Treatment in patients who are not eligible for intravenous alteplase: MR CLEAN subgroup analysis.
Saved in:
| Title: | Treatment in patients who are not eligible for intravenous alteplase: MR CLEAN subgroup analysis. |
|---|---|
| Authors: | Mulder MJ; Erasmus University Medical Center, Rotterdam, the Netherlands m.mulder@erasmusmc.nl., Berkhemer OA; Academic Medical Center, Amsterdam, the Netherlands., Fransen PS; Erasmus University Medical Center, Rotterdam, the Netherlands., Beumer D; Maastricht University Medical Center, Maastricht, Cardiovascular Research Institute Maastricht (CARIM), the Netherlands., van den Berg LA; Academic Medical Center, Amsterdam, the Netherlands., Lingsma HF; Erasmus University Medical Center, Rotterdam, the Netherlands., Roos YB; Academic Medical Center, Amsterdam, the Netherlands., van Oostenbrugge RJ; Maastricht University Medical Center, Maastricht, Cardiovascular Research Institute Maastricht (CARIM), the Netherlands., van Zwam WH; Maastricht University Medical Center, Maastricht, Cardiovascular Research Institute Maastricht (CARIM), the Netherlands., Majoie CB; Academic Medical Center, Amsterdam, the Netherlands., van der Lugt A; Erasmus University Medical Center, Rotterdam, the Netherlands., Dippel DW; Erasmus University Medical Center, Rotterdam, the Netherlands. |
| Corporate Authors: | MR CLEAN investigators |
| Source: | International journal of stroke : official journal of the International Stroke Society [Int J Stroke] 2016 Aug; Vol. 11 (6), pp. 637-45. Date of Electronic Publication: 2016 Apr 05. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: SAGE Publications Country of Publication: United States NLM ID: 101274068 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1747-4949 (Electronic) Linking ISSN: 17474930 NLM ISO Abbreviation: Int J Stroke Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
